Karson S. Putt
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Immunology top 10%
Papers in
-
- Enzyme function and inhibition 4
- Cell death mechanisms and regulation 3
- Phosphodiesterase function and regulation 2
- 14-3-3 protein interactions 2
- RNA Interference and Gene Delivery 2
- Retinoids in leukemia and cellular processes 2
- Oncology 14
- PARP inhibition in cancer therapy 6
- Co-authors
- Paul J. Hergenrother (12 shared papers)Philip S. Low (20 shared papers)Scott Poh (3 shared papers)Robin S. Dothager (4 shared papers)Jung‐Taek Kwon (1 shared paper)William G. Helferich (1 shared paper)Hua Jin (1 shared paper)Martin S. Hoagland (1 shared paper)
- Journals
- Oncotarget (3 papers)Analytical Biochemistry (2 papers)Journal of the American Chemical Society (2 papers)ChemBioChem (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesIndiaPuerto Rico
In The Last Decade
Karson S. Putt
41 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Oncology 399
- Immunology 212
- Molecular Biology 689
- Organic Chemistry 249
- Physiology 38
Countries citing papers authored by Karson S. Putt
This map shows the geographic impact of Karson S. Putt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karson S. Putt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karson S. Putt more than expected).
Fields of papers citing papers by Karson S. Putt
This network shows the impact of papers produced by Karson S. Putt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karson S. Putt. The network helps show where Karson S. Putt may publish in the future.
Co-authors
The 25 scholars most cited alongside Karson S. Putt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 296 | |
| 2 | 2004 | 107 | |
| 3 | 2005 | 92 | |
| 4 | 2019 | 86 | |
| 5 | 2015 | 80 | |
| 6 | 2015 | 72 | |
| 7 | 2017 | 69 | |
| 8 | 2003 | 68 | |
| 9 | 2008 | 56 | |
| 10 | 2018 | 51 | |
| 11 | 2017 | 49 | |
| 12 | 2019 | 39 | |
| 13 | 2016 | 37 | |
| 14 | 2017 | 36 | |
| 15 | 2016 | 35 | |
| 16 | 2022 | 29 | |
| 17 | 2004 | 29 | |
| 18 | 2021 | 28 | |
| 19 | 2004 | 27 | |
| 20 | 2006 | 26 |
About Karson S. Putt
Karson S. Putt is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, having authored 42 papers that have together received 1.5k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), Enzyme function and inhibition (4 papers), Cell death mechanisms and regulation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Phosphodiesterase function and regulation (2 papers), 14-3-3 protein interactions (2 papers), RNA Interference and Gene Delivery (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Oncology (399 citations), Immunology (212 citations), Molecular Biology (689 citations), Organic Chemistry (249 citations) and Physiology (38 citations). Karson S. Putt has collaborated with scholars based in United States, India and Puerto Rico. Frequent co-authors include Paul J. Hergenrother, Philip S. Low, Scott Poh, Robin S. Dothager, Jung‐Taek Kwon, William G. Helferich, Hua Jin, Martin S. Hoagland, Daniel R. Doerge and Myung‐Haing Cho. Their work appears in journals such as Oncotarget, Analytical Biochemistry, Journal of the American Chemical Society, ChemBioChem and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.